The OpenAI CEO is adding a well-funded brain-computer interface startup to his growing portfolio of ambitious bets.
Merge Labs is a “research lab” dedicated to “bridging biological and artificial intelligence to maximize human ability.” ...
LumiMind debuts real-time non-invasive brain computer interfaces at CES 2026, pairing live gameplay demos with LumiSleep, a ...
OpenAI leads a major seed round in Sam Altman’s Merge Labs to develop advanced, non-invasive brain-computer interfaces with ...
In August, the Financial Times reported that OpenAI Chief Executive Officer Sam Altman is part of Merger Labs’ founding team ...
A new, high-performance brain-computer interface (BCI) can be rapidly implanted through a minimally invasive procedure. The new BCI solution has been implanted in over 50 patients.
As the momentum and interest in brain-computer interface (BCI) technologies continue to accelerate, Merge Labs has emerged ...
The financial terms of the investment were not disclosed. The move signals OpenAI’s growing interest in technologies that ...
Tom's Hardware on MSN
OpenAI CEO Sam Altman raises $252 million for brain computer interface venture — but Merge Labs is still in an early research phase
OpenAI has signaled its intentions to become a major player in brain computer interfaces (BCIs) with a $252 million ...
Precision Neuroscience today announced a strategic partnership with Medtronic to leverage brain-computer interface (BCI) ...
OpenAI-backed Merge Labs is working to safely interface biology, hardware devices, and AI at higher bandwidth.
Medtronic will integrate Precision Neuroscience’s Layer 7 cortical interface with its StealthStation surgical navigation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback